Levofloxacin Inhalation Solution (MP-376) in Patients with Cystic Fibrosis with Pseudomonas aeruginosa

Lower respiratory tract infection with Pseudomonas aeruginosa (PA) is associated with increased morbidity in patients with cystic fibrosis (CF). Current treatment guidelines for inhaled antibiotics are not universally followed due to the perception of decreased efficacy, increasing resistance, drug...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of respiratory and critical care medicine 2011-06, Vol.183 (11), p.1510-1516
Hauptverfasser:	GELLER, David E, FLUME, Patrick A, STAAB, Doris, FISCHER, Rainald, LOUTIT, Jeffery S, CONRAD, Douglas J
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Inhalation Adult Aerosols Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Anti-Bacterial Agents - administration & dosage Antibiotics Biological and medical sciences Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis Cystic fibrosis Cystic Fibrosis - complications Dose-Response Relationship, Drug Double-Blind Method Drug dosages Female Humans Infections Intensive care medicine Levofloxacin Lung diseases Medical sciences Ofloxacin - administration & dosage Pathogens Patients Pseudomonas aeruginosa - drug effects Pseudomonas Infections - complications Pseudomonas Infections - drug therapy Respiratory Function Tests Solutions Sputum - microbiology Transfusions. Complications. Transfusion reactions. Cell and gene therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!